Heinzerling John H, Hampton Carnell J, Robinson Myra, Bright Megan, Moeller Benjamin J, Ruiz Justin, Prabhu Roshan, Burri Stuart H, Foster Ryan D
Levine Cancer Institute, Southeast Radiation Oncology Group, Atrium Health, Charlotte, NC, USA.
Levine Cancer Institute, Department of Radiation Oncology, Atrium Health, Charlotte, NC, USA.
J Appl Clin Med Phys. 2020 May;21(5):48-55. doi: 10.1002/acm2.12852. Epub 2020 Mar 20.
Multiple techniques can be used to assist with more accurate patient setup and monitoring during Stereotactic body radiation therapy (SBRT) treatment. This study analyzes the accuracy of 3D surface mapping with Surface-guided radiation therapy (SGRT) in detecting interfraction setup error and intrafraction motion during SBRT treatments of the lung and abdomen.
Seventy-one patients with 85 malignant thoracic or abdominal tumors treated with SBRT were analyzed. For initial patient setup, an alternating scheme of kV/kV imaging or SGRT was followed by cone beam computed tomography (CBCT) for more accurate tumor volumetric localization. The CBCT six degree shifts after initial setup with each method were recorded to assess interfraction setup error. Patients were then monitored continuously with SGRT during treatment. If an intrafractional shift in any direction >2 mm for longer than 2 sec was detected by SGRT, then CBCT was repeated and the recorded deltas were compared to those detected by SGRT.
Interfractional shifts after SGRT setup and CBCT were small in all directions with mean values of <5 mm and < 0.5 degrees in all directions. Additionally, 25 patients had detected intrafraction motion by SGRT during a total of 34 fractions. This resulted in 25 (73.5%) additional shifts of at least 2 mm on subsequent CBCT. When comparing the average vector detected shift by SGRT to the resulting vector shift on subsequent CBCT, no significant difference was found between the two.
Surface-guided radiation therapy provides initial setup within 5 mm for patients treated with SBRT and can be used in place of skin marks or planar kV imaging prior to CBCT. In addition, continuous monitoring with SGRT during treatment was valuable in detecting potentially clinically meaningful intrafraction motion and was comparable in magnitude to shifts from additional CBCT scans. PTV margin reduction may be feasible for SBRT in the lung and abdomen when using SGRT for continuous patient monitoring during treatment.
在立体定向体部放射治疗(SBRT)过程中,可采用多种技术辅助进行更精确的患者摆位和监测。本研究分析了表面引导放射治疗(SGRT)的三维表面映射在检测肺部和腹部SBRT治疗期间的分次间摆位误差和分次内运动方面的准确性。
分析了71例接受SBRT治疗的85个恶性胸部或腹部肿瘤患者。对于初始患者摆位,采用千伏/千伏成像或SGRT的交替方案,随后进行锥形束计算机断层扫描(CBCT)以实现更精确的肿瘤体积定位。记录每种方法初始摆位后CBCT的六维移位,以评估分次间摆位误差。然后在治疗期间用SGRT对患者进行连续监测。如果SGRT检测到在任何方向上的分次内移位>2 mm且持续时间超过2秒,则重复CBCT,并将记录的移位与SGRT检测到的移位进行比较。
SGRT摆位和CBCT后的分次间移位在所有方向上都很小,所有方向的平均值<5 mm且<0.5度。此外,25例患者在总共34个分次中被SGRT检测到分次内运动。这导致在随后的CBCT上又出现了25次(73.5%)至少2 mm的移位。当比较SGRT检测到的平均矢量移位与随后CBCT上产生的矢量移位时,两者之间未发现显著差异。
表面引导放射治疗为接受SBRT治疗的患者提供了5 mm以内的初始摆位,可在CBCT之前替代皮肤标记或平面千伏成像。此外,在治疗期间用SGRT进行连续监测对于检测潜在的具有临床意义的分次内运动很有价值,并且在幅度上与额外CBCT扫描的移位相当。在治疗期间使用SGRT对患者进行连续监测时,对于肺部和腹部的SBRT,计划靶体积边缘缩小可能是可行的。